Business process improvement strategic management

Ended Awarded Last action

Contract number
HHSF223201010014B
Awardee
Awarding agency
Task orders
45 $55,183,904 obligated

Award facts

Combined order value
  • $55,183,904 Current, with exercised options
  • $94,783,723 Potential, with all options
Last date to order 100% complete
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

The Food and Drug Administration established a Blanket Purchase Agreement with McKinsey & Company, Inc. Washington D.c. on April 15, 2010, against The Professional Services Schedule (PSS) for business process improvement and strategic management consulting services.

The PSS is a GSA Multiple Award Schedule providing access to professional services across management consulting, organizational transformation, strategic planning, and program implementation. Place of performance spans Rockville, Maryland and Washington, D.C., with performance locations varying by individual BPA call. The ultimate completion date for the BPA was October 14, 2015.

BPA calls issued under this vehicle span fiscal years 2010 through 2015 and total approximately $102.9 million across more than 40 task orders. Notable recent calls include organizational assessment and business process improvement ($4.47 million, April 2014); stabilizing FDA IT infrastructure ($10.58 million, May 2012); developing operational excellence in the Office of Health Communications and Education ($6.91 million, June 2012); CDER informatics strategic capabilities operationalization and commercialization ($7.93 million, July 2013); and resource analysis for globalization ($5.79 million, September 2012). Additional calls addressed Center for Drug Evaluation and Research strategic portfolio management consulting ($1.65 million, August 2015); workforce development initiatives ($2.05 million, July 2015); integrating Sentinel capabilities into regulatory workflows ($2.64 million, July 2015); and developing world-class research programs for the Center for Biologics Evaluation and Research ($2.99 million, February 2015). All calls were firm fixed-price with no set-aside designation.

Task orders

Task order Ordering agency Obligated Awarded
Center for drug evaluation and research (cder) office of management (OM) strategic portfolio management consulting HHSF22315007 Food and Drug Administration $1,647,675
Building and developing the workforce of the future for FDA office operations, office of human resources HHSF22315006 Food and Drug Administration $2,053,768
Cder - integrating sentinel capabilities into cder regulatory workflows HHSF22315005 Food and Drug Administration $2,641,441
Physical security access control system requirements documentation for FDA office of operations, office of security… HHSF22315004 Food and Drug Administration $662,677
Developing and maintaining world-class mission-relevant research program for the center for biologics evaluation and… HHSF22315003 Food and Drug Administration $2,987,514
Strategic planning for the FDA office of operations HHSF22315001 Food and Drug Administration $1,732,292
Incident assessment and response planning HHSF22315002 Food and Drug Administration $1,492,576
For closely associated HHSF22314001 Food and Drug Administration $1,489,962
Organizational assessment and business process improvement HHSF22314003 Food and Drug Administration $2,172,043
Center for projects to support the office of generic drugs under the generic drug user fee amendments ?closely… HHSF22313004 Food and Drug Administration $719,438
Cder informatics strategic capabilities operationalization and commercialization HHSF22313003 Food and Drug Administration $2,580,989
HHSF22313002 Food and Drug Administration $1,166,071
OO budget process improvements-mission critical HHSF22312015 Food and Drug Administration $986,987
Assessment of, and business process improvement recommendations for, FDA physical security, personnel security and… HHSF22312014 Food and Drug Administration $1,214,244
FDA360 project closely associated HHSF22312013 Food and Drug Administration $686,703
Rulemaking improvement project HHSF22312012 Food and Drug Administration $970,642
Resource analysis for globalization-closely associated HHSF22312011 Food and Drug Administration $2,843,655
Developing a risk-based complaints handling process within OSI (human subject protection)- closely associated HHSF22312010 Food and Drug Administration $337,615
Closely associated - business process improvement gdufa inspectional and compliance policy programs HHSF22312009 Food and Drug Administration $790,435
Other functions- integrated process maps HHSF22312008 Food and Drug Administration $619,780
Improving the quality of processes and organization of OBE-mission critical HHSF22312007 Food and Drug Administration $523,053
Cap cdrh OMO 12-050 business process improvements to enhance medical device software pre and post-market review… HHSF22312006 Food and Drug Administration $694,901
Developing operational excellence in the office of health communications and education-missioncritical function HHSF22312005 Food and Drug Administration $1,686,187
OIM 12 IO FDA assmt OIM 423 1 CA stabilizing FDA IT infrastructure FDA IT first wave in phase 3 HHSF22312004 Food and Drug Administration $2,318,790
OIM 12 IO MOD FDA assesmt OIM 423 modernizing FDA IT infrastructure and systems to conduct an assessment to modernize… HHSF22312003 Food and Drug Administration $284,217
CTP 12-043 new non-competitive BPA call mckinsey HHSF223201010014B OM change management HHSF22312002 Food and Drug Administration $1,041,044
Development of a risk-based resource allocation tool for the FDA foods program HHSF22311010 Food and Drug Administration $954,754
Designing the next generation organizational model for FDA's operational activities HHSF22311009 Food and Drug Administration $1,395,795
Real time clinical trial inspections business process improvement task order HHSF22311008 Food and Drug Administration $712,480
Developing standards for track and trace and authentication HHSF22311007 Food and Drug Administration $730,381
Implement OSE concept of operations HHSF22311006 Food and Drug Administration $303,508
Enhancement of quality best practices within cdrh HHSF22311005 Food and Drug Administration $527,604
Task for process improve effort that will enable challenge in the current review processes as well as the oppor for… HHSF22311004 Food and Drug Administration $789,963
Improving FDA's IT model HHSF22311003 Food and Drug Administration $569,617
TAS 75 0600 TAS develop concept of operations for center for drug evaluation and research (cder) office of surveillance… HHSF22311002 Food and Drug Administration $1,717,510
Consulting services for FDA's standards development for track and trace and authentication systems for prescription… HHSF22301011 Food and Drug Administration $1,620,967
Business process improvement for enhancement of the recall process HHSF22301010 Food and Drug Administration $1,539,149
Business process improvement for cdrh to develop top data to assess barriers with industry and FDA HHSF22301009 Food and Drug Administration $910,809
Refreshing and launching the office of pharmaceutical sciences QBD roadmap cap cder-10-OPS-468 HHSF22301008 Food and Drug Administration $657,779
Mckinsey-OPS task understanding and addressing the OGD review process and queue management cap cder-10-OPS-467 HHSF22301007 Food and Drug Administration $1,026,707
Business process improvements for conversion studies HHSF22301006 Food and Drug Administration $600,935
Business process improvement for foreign inspection MOD 4 HHSF22301005 Food and Drug Administration $1,266,745
Global product safety action plan HHSF22301003 Food and Drug Administration $1,827,957
Bioequivalence inspection program HHSF22301004 Food and Drug Administration $633,222
Business process improvement - high throughput and pharmaceutical inspectorate task order 1 HHSF22301002 Food and Drug Administration $1,053,323
Show all 45

Transactions

Action Obligated Date
Change Order 2 $0
Other Administrative Action 1 · BPI strategic management SOW $0
Original award $0

Quick answers

Who was awarded contract HHSF223201010014B?

HHSF223201010014B was awarded to Mckinsey & Company, Inc. Washington D.c. by Food and Drug Administration (Department of Health and Human Services) on April 15, 2010.

How much is contract HHSF223201010014B worth?

Orders under HHSF223201010014B have obligated $55,183,904. Their combined potential value, with all options, is $94,783,723.

How many orders have been placed under contract HHSF223201010014B?

45 orders have been placed under HHSF223201010014B, the latest on August 20, 2015.

Who can order from contract HHSF223201010014B?

HHSF223201010014B is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract HHSF223201010014B under another contract?

Yes. HHSF223201010014B is a blanket purchase agreement under GS10F0118S, a federal supply schedule, on The Professional Services Schedule (PSS).

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login